nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A patient with B-cell acute lymphoblastic leukemia with PAX5-ETV6 rearrangement with dic(9;12)(p13;p13) identified by chromosomal microarray
|
Ha, Jihye |
|
2018 |
97 |
8 |
p. 1505-1507 |
artikel |
2 |
Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes
|
Montoro, Julia |
|
2018 |
97 |
8 |
p. 1349-1356 |
artikel |
3 |
BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
|
Zhang, Jilei |
|
2018 |
97 |
8 |
p. 1391-1397 |
artikel |
4 |
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia
|
Paludo, Jonas |
|
2018 |
97 |
8 |
p. 1417-1425 |
artikel |
5 |
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis
|
Hong, Jung Yong |
|
2018 |
97 |
8 |
p. 1437-1443 |
artikel |
6 |
Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphoma
|
Nakazato, Tomonori |
|
2018 |
97 |
8 |
p. 1489-1491 |
artikel |
7 |
Clinical impact of underweight status at diagnosis on elderly patients with acute myeloid leukemia: a retrospective study of JALSG GML200
|
Harada, Kaito |
|
2018 |
97 |
8 |
p. 1481-1483 |
artikel |
8 |
Comorbidities, repeated hospitalizations, and age ≥ 80 years as indicators of anemia development in the older population
|
Michalak, Sylwia Sulimiera |
|
2018 |
97 |
8 |
p. 1337-1347 |
artikel |
9 |
Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiae
|
Marks, Reinhard |
|
2018 |
97 |
8 |
p. 1497-1500 |
artikel |
10 |
Eculizumab treatment for ischemic enteritis accompanied with paroxysmal nocturnal hemoglobinuria: a case report and literature review
|
Yasunaga, Megumi |
|
2018 |
97 |
8 |
p. 1513-1515 |
artikel |
11 |
Efficacy and safety of decitabine against cutaneous granuloblastic sarcoma: a case report
|
Castelli, Andrea |
|
2018 |
97 |
8 |
p. 1485-1486 |
artikel |
12 |
Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin’s lymphomas: evidence from a meta-analysis
|
Huang, Yi-shu |
|
2018 |
97 |
8 |
p. 1317-1325 |
artikel |
13 |
Eltrombopag as initial monotherapy for severe aplastic anemia—a case report
|
Rodgers, George M. |
|
2018 |
97 |
8 |
p. 1517-1518 |
artikel |
14 |
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients
|
González-Calle, Verónica |
|
2018 |
97 |
8 |
p. 1453-1462 |
artikel |
15 |
IgG synthesis rate and anti-myelin oligodendrocyte glycoprotein antibody in CSF may be associated with the onset of CNS demyelination after haplo-HSCT
|
Zhang, Xiao-hui |
|
2018 |
97 |
8 |
p. 1399-1406 |
artikel |
16 |
Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma
|
Yamasaki, Satoshi |
|
2018 |
97 |
8 |
p. 1445-1452 |
artikel |
17 |
Isolated Richter’s syndrome of the brain: diagnosis in the eye of the beholder
|
Pinto, Ana Luísa |
|
2018 |
97 |
8 |
p. 1509-1511 |
artikel |
18 |
Large granular lymphocytic leukemia-associated peripheral neuropathy
|
Saini, Neeraj Y |
|
2018 |
97 |
8 |
p. 1501-1504 |
artikel |
19 |
Late-onset hemophagocytic lymphohistiocytosis with varicella zoster virus and Epstein-Barr virus co-infection after umbilical cord blood transplantation
|
Ono, Koya |
|
2018 |
97 |
8 |
p. 1493-1495 |
artikel |
20 |
Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis
|
Pelzer, Benedikt W. |
|
2018 |
97 |
8 |
p. 1463-1469 |
artikel |
21 |
Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia
|
Wang, Xinfeng |
|
2018 |
97 |
8 |
p. 1375-1389 |
artikel |
22 |
Major response of PNH to an AML chemotherapy protocol
|
Füreder, Wolfgang |
|
2018 |
97 |
8 |
p. 1487-1488 |
artikel |
23 |
Necrobiotic xanthogranuloma: a 30-year single-center experience
|
Hilal, Talal |
|
2018 |
97 |
8 |
p. 1471-1479 |
artikel |
24 |
Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international study
|
Mascarenhas, J. |
|
2018 |
97 |
8 |
p. 1369-1374 |
artikel |
25 |
Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study
|
Kim, Dong-Wook |
|
2018 |
97 |
8 |
p. 1357-1367 |
artikel |
26 |
Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma
|
Cho, Jinhyun |
|
2018 |
97 |
8 |
p. 1427-1436 |
artikel |
27 |
Temporal trajectory of quality of life and its predictors in recipients of hematopoietic stem cell transplantation
|
Kim, Ryul |
|
2018 |
97 |
8 |
p. 1407-1415 |
artikel |
28 |
The severe cytokine release syndrome in phase I trials of CD19-CAR-T cell therapy: a systematic review
|
Jin, Zhen |
|
2018 |
97 |
8 |
p. 1327-1335 |
artikel |
29 |
Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors
|
Carella, A. M. |
|
2018 |
97 |
8 |
p. 1301-1315 |
artikel |